Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Mouhamed D Moussa, Jérôme Soquet, Emmanuel Robin, Julien Labreuche, Natacha Rousse, Antoine Rauch, Valentin Loobuyck, Guillaume Leroy, Thibault Duburcq, Guillaume Gantois, Xavier Leroy, Slimane Ait-Ouarab, Antoine Lamer, Lise Thellier, Oliver Lukowiak, Guillaume Schurtz, Christophe Muller, Francis Juthier, Sophie Susen, André Vincentelli
PURPOSE: The severity of bleeding events is heterogeneously defined during peripheral veno-arterial extracorporeal membrane oxygenation (pVA-ECMO). We studied three bleeding definitions in pVA-ECMO: the Extracorporeal Life Support Organization (ELSO)-serious bleeding, the Bleeding Academic Research Consortium (BARC), and the universal definition of postoperative bleeding (UPDB) classifications. METHODS: We included consecutive adult patients supported by pVA-ECMO for refractory cardiogenic shock admitted to Lille academic hospitals between January 2013 and December 2019...
March 4, 2024: Canadian Journal of Anaesthesia
#2
JOURNAL ARTICLE
Kenji Hosoi, Yoshikazu Ohtsuka, Tohru Fujii, Takahiro Kudo, Nobuaki Matsunaga, Takeshi Tomomasa, Hitoshi Tajiri, Reiko Kunisaki, Takashi Ishige, Hiroyuki Yamada, Katsuhiro Arai, Atsushi Yoden, Kosuke Ushijima, Tomoki Aomatsu, Satoru Nagata, Keiichi Uchida, Kazuo Takeuchi, Toshiaki Shimizu
BACKGROUND AND AIM: Childhood-onset inflammatory bowel disease (IBD) is characterized by extensive intestinal involvement and rapid early progression. Infliximab (IFX), cyclosporin (CYA), and tacrolimus (FK506) are increasingly used to treat pediatric IBD; however, their long-term effects and adverse events have not been properly investigated in pediatric patients. The aim of this study was to characterize the effects of these biologics and immunomodulators on pediatric IBD patients in Japan...
January 2017: Journal of Gastroenterology and Hepatology
#3
MULTICENTER STUDY
A-L Tarbé de Saint Hardouin, P Mariani, V Esteve, J-C Msélati, M Lorrot, A Blachier, Y Aujard, S Bonacorsi, A Faye
BACKGROUND: Very few studies describe group B streptococcal dermo-hypodermitis in newborns. OBJECTIVES: To describe the incidence, clinical characteristics, and course of group B streptococcal dermo-hypodermitis in infants less than 3 months old. PATIENTS AND METHODS: Infants under 3 months of age, hospitalized for group B streptococcal dermo-hypodermitis at Robert Debré University Hospital, Paris, France, and at Orsay Hospital, Orsay, France, between January 2002 and August 2013, were included in a retrospective study...
July 2015: Archives de Pédiatrie: Organe Officiel de la Sociéte Française de Pédiatrie
#4
REVIEW
Emmanuel Broussolle, Florent Gobert, Teodor Danaila, Stéphane Thobois, Olivier Walusinski, Julien Bogousslavsky
This historical review presents the advances made mostly during the last 200 years on the description, concepts, theories, and (more specifically) cure of patients suffering from hysteria, a still obscure entity. The denomination of the syndrome has changed over time, from hysteria (reinvestigated by Paul Briquet and Jean-Martin Charcot) to pithiatism (Joseph Babinski), then to conversion neurosis (Sigmund Freud), and today functional neurological disorders according to the 2013 American Neurological Association DSM-5 classification...
2014: Frontiers of Neurology and Neuroscience
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
